Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue

European Journal of Pharmacology

Volumn 515, Issue 1-3, 2005, Pages 20-27

  Sánchez, María G ^a   Sánchez, Ana M ^a   Collado, Beatriz ^a   Malagarie Cazenave, Sophie ^a   Olea, Nuria ^a   Carmena, María J ^a   Prieto, Juan C ^a   Díaz Laviada, Inés ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Capsaicin; Prostate; TRPV1; Vanilloids

Indexed keywords

CAPSAICIN; CAPSAZEPINE; FURA 2; IODINE 125; METHANANDAMIDE; RESINIFERATOXIN; VANILLOID RECEPTOR 1;

ADULT; AGED; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CALCIUM CELL LEVEL; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; DOSE RESPONSE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ARACHIDONIC ACIDS; BINDING, COMPETITIVE; BLOTTING, WESTERN; CALCIUM; CAPSAICIN; CELL LINE, TUMOR; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HUMANS; IODINE RADIOISOTOPES; ION CHANNELS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIOLIGAND ASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRPV CATION CHANNELS;

EID: 20344384533     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.04.010     Document Type: Article

References (38)

1. G. Acs, T. Biro, P. Acs, S. Modarres, and P.M. Blumberg Differential activation and desensitisation of sensory neurons by resiniferatoxin J. Neurosci. 17 1997 5622 5628
2. A. Avelino, C. Cruz, I. Nagy, and F. Cruz Vanilloid receptor 1 expression in the rat urinary tract Neuroscience 109 2002 787 798
3. L.A. Birder, A.J. Kanai, W.C. Groat, S. Kiss, M.L. Nealen, N.E. Burke, K.E. Dineley, S. Watkins, I.J. Reynolds, and M.J. Caterina Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells Proc. Natl. Acad, Sci. U. S. A. 98 2001 13396 13401
4. 2+ current and TRPV6 channels in lymph node prostate cancer cells J. Biol. Chem. 278 2003 50872 50879
5. M.J. Caterina Vanilloid receptors take a TRP beyond the sensory afferent Pain 105 2003 5 9
6. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Roston, J.D. Levine, and D. Julius The capsaicin receptor: a heat-activated ion channel in the pain pathway Nature 389 1997 816 824
7. E. Contassot, R. Wilmotte, M. Tenan, M.C. Belkouch, V. Schnuriger, N. de Tribolet, K. Burkhardt, and P.Y. Dietrich Arachidonylethanolamine induces apoptosis in human glioma cells through vanilloid receptor-1 J. Neuropathol. Exp. Neurol. 63 2004 956 963
8. D.N. Cortright, and A. Szallasi Biochemical pharmacology of the vanilloid receptor TRPV1. An update Eur. J. Biochem. 271 2004 1814 1819
9. M. Denda, S. Fuziwara, K. Inoue, S. Denda, H. Akamatsu, A. Tomitaka, and K. Matsunaga Immunoreactivity of VR1 on epidermal keratinocyte of human skin Biochem. Biophys. Res. Commun. 285 2001 1250 1252
10. I. Diaz-Laviada, P. Larrodera, J.L. Nieto, M.E. Cornet, M.T. Diaz-Meco, M.J. Sanchez, P.H. Guddal, T. Johansen, A. Haro, and J. Moscat Mechanism of inhibition of adenylate cyclase by phospholipase C-catalyzed hydrolysis of phosphatidylcholine. Involvement of a pertussis toxin-sensitive G protein and protein kinase C J. Biol. Chem. 5 1991 1170 1176
11. A. Ferrer-Montiel, C. García-Martínez, C. Morenilla-Palao, N. García-Sanz, A. Fernández-Carvajal, G. Fernández- Ballester, and R. Planeéis-Cases Molecular architecture of the vanilloid receptor. Insights for drug design Eur. J. Biochem. 271 2004 1820 1826
12. 2+ indicators with greatly improved fluorescence properties J. Biol. Chem. 260 1985 3440 3450
13. P. Hayes, H.J. Meadows, M.J. Gunthorpe, M.H. Harries, D.M. Duckworth, W. Cairns, D.C. Harrison, C.E. Clarke, K. Ellington, R.K. Prinjha, A.J. Barton, A.D. Medhurst, G.D. Smith, S. Topp, P. Murdock, G.J. Sanger, J. Terrett, O. Jenkins, C.D. Benham, A.D. Randall, I.S. Gloger, and J.B. Davis Cloning and functional expression of a human orthologue of rat vanilloid receptor-1 Pain 88 2000 205 215
14. C.L. Huang The transient receptor potential superfamily of ion channels J. Am. Soc. Nephrol. 15 2004 1690 1699
15. S.M. Huang, T. Bisogno, M. Trevisani, A. Al-Hayani, L. De Petrocellis, F. Fezza, M. Tognetto, T.J. Petros, J.F. Krey, C.J. Chu, J.D. Miller, S.N. Davies, P. Geppetti, J.M. Walker, and V. Di Marzo An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors Proc. Natl. Acad. Sci. U. S. A. 99 2002 8400 8405
16. N. Kedei, T. Szabo, J.D. Lile, J.J. Treanor, Z. Olah, M.J. Iadarola, and P.M. Blumberg Analysis of the native quaternary structure of vanilloid receptor 1 J. Biol. Chem. 276 2001 28613 28619
17. M. Maccarrone, T. Lorenzon, M. Bari, G. Melino, and A. Finazzi-Agro Anandamide induces apoptosis in human cells via vanilloid receptors J. Biol. Chem. 275 2000 31938 31945
18. D. Melck, L. de Petrocellis, P. Orlando, T. Bisogno, C. Laczza, M. Bifulco, and V. Di Marzo Supression of nerve growth factor Trk receptors and prolactin by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation Endocrinol. 141 2000 118 126
19. E. Mezey, Z.E. Toth, D.N. Cortrigh, M.K. Arzubi, J.E. Krause, R. Elde, A. Guo, P.M. Blumberg, and A. Szallasi Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human Proc. Natl. Acad. Sci. U. S. A. 97 2000 3655 3660
20. M. Mimault, N. Pommery, N. Wattez, C. Bailly, and J. Hénichart Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide-production Prostate 56 2003 1 12
21. M.M. Moran, H. Xu, and D.E. Clapham TRP ion channels in the nervous system Curr. Opin. Neurobiol. 14 2004 362 369
22. D. Ost, T. Roskams, F. Van Der Aa, and D. De Ridder Topography of the vanilloid receptor in the human bladder: more than just the nerve fibers J. Urol. 168 2002 293 297
23. V. Ralevic, D.A. Kendall, J.C. Jerman, D.N. Middlemiss, and D. Smart Cannabinoid activation of recombinant and endogenous vanilloid receptors Eur. J. Pharmacol. 424 2001 211 219
24. R.A. Ross, T.M. Gibson, H.C. Brockie, M. Leslie, G. Pashmi, S.J. Craib, V. Di Marzo, and R.G. Pertwee Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens Br. J. Pharmacol. 132 2001 631 640
25. 9- Tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism FEBS Lett. 458 1999 400 404
26. J.F. Sanchez, J.E. Krause, and D.N. Cortright The distribution and regulation of vanilloid receptor VR1 and VR1 5′ splice variant RNA expression in rat Neuroscience 107 2001 373 381
27. A. Someya, K. Kunieda, N. Akiyama, T. Hirabayashi, S. Horie, and T. Murayama Expression of vanilloid VR1 receptor in PC12 cells Neurochem. Int. 45 2004 1005 1010
28. S. Stander, C. Moormann, M. Schumacher, J. Buddenkotte, M. Artuc, V. Shpacovitch, T. Brzoska, U. Lippert, B.M. Henz, T.A. Luger, D. Metze, and M. Steinhoff Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures Exp. Dermatol. 13 2004 129 139
29. R.J. Stein, S. Santos, J. Nagatomi, Y. Hayashi, B.S. Minnery, M. Xavier, A.S. Patel, J.B. Nelson, W.J. Futrell, N. Yoshimura, M.B. Chancellor, and F. De Miguel Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract J. Urol. 172 2004 1175 1178
30. T. Szabo, T. Biro, A.F. Gonzalez, M. Palkovits, and P.M. Blumberg Pharmacological characterization of vanilloid receptor located in the brain Mol. Brain Res. 98 2002 51 57
31. A. Szallasi, and P.M. Blumberg Vanilloid receptor loss in rat sensory ganglia associated with long term desensitisation to resiniferatoxin Neurosci. Lett. 140 1992 51 54
32. 3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat J. Pharmacol. Exp. Ther. 267 1993 728 733
33. 2+ transporter type 1 J. Biol. Chem. 278 2003 15381 15389
34. F. Van der Aa, T. Roskams, W. Blyweert, and D. De Ridder Interstitial cells in the human prostate: a new therapeutic target? Prostate 56 2003 250 255
35. M. Van der Stelt, and V. Di Marzo Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels Eur. J. Biochem. 271 2004 1827 1834
36. P. Wahl, C. Foged, S. Tullin, and C. Thomsen Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist Mol. Pharmacol. 59 2001 9 15
37. S.M. Ward, J. Bayguinov, K.J. Won, D. Grundy, and H.R. Berthoud Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract J. Comp. Neurol. 465 2003 121 135
38. 2+ channel required for the survival of prostate cancer cells Cancer Res. 64 2004 8365 8373